1 / 14

Konstantin Slavin, MD Prasad Vannemreddy, MBBS, MS Eduardo Goellner, MD

Use of Cervical Spinal Cord Stimulation to Treat and Prevent Arterial Vasospasm after Aneurysmal Subarachnoid Hemorrhage. Konstantin Slavin, MD Prasad Vannemreddy, MBBS, MS Eduardo Goellner, MD

baba
Download Presentation

Konstantin Slavin, MD Prasad Vannemreddy, MBBS, MS Eduardo Goellner, MD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Use of Cervical Spinal Cord Stimulation to Treat and Prevent Arterial Vasospasm after AneurysmalSubarachnoid Hemorrhage Konstantin Slavin, MD Prasad Vannemreddy, MBBS, MS Eduardo Goellner, MD Ali Alaraj, MD; Nada Mlinarevich, RN, MPH; Karriem Watson, MD; Leena E. Walters, BS; Sepideh Amin-Hanjani, MD; Victor Aletich, MD; Fady T. Charbel, MD Department of Neurosurgery University of Illinois at Chicago Bologna 2010

  2. Background CBF changes with SCS (Hosobuchi, 1985) 10 patient study (Takanashi, 2000) Bologna 2010

  3. First hypothesis Based on past laboratory and anecdotal clinical experience, we hypothesized that prolonged cervical spinal cord stimulation (cSCS) in acute settings of aneurysmal subarachnoid hemorrhage (aSAH) would be both safe and feasible, and that 2-week stimulation will reduce incidence of cerebral arterial vasospasm. Bologna 2010

  4. Cervical SCS for Vasospasm IDE study No commercial sponsor / investigator initiated Safety / feasibility Acute study, long-term follow up Single arm – no placebo / control group No blinding / randomization 12 patients Single cervical SCS electrode - externalized 14 days of stimulation Daily spasm monitoring (TCD, CT, CTA, angio) 3, 6 and 12 months follow up Bologna 2010

  5. Cervical SCS for Vasospasm Procedure Single 8-contact electrode Insertion at C7-T1 or T1-2 Midline placement up to C2 Posterior epidural space Immediately upon completion of aneurysm-securing procedure General anesthesia Lateral position Subcutaneous tunneling Bologna 2010

  6. Patient Data Age: 27-62 (mean – 49) 4 men, 8 women H&H – 2.9, Fisher – 3.3 3 coiled, 9 clipped 5 AComm, 3 PComm, 2 MCA, 1 ICA, 1 pericallosal Recruitment pattern Bologna 2010

  7. Results 1 death (multi-system failure) 2 electrode pullouts (days #7 and 13) 0 insertion complications 0 infections 0 CSF leaks Bologna 2010

  8. Results No issues with feasibility “Treatment as usual” Daily TCD; CT and angio as needed Stimulation parameters: Frequency – 60 Hz Pulse width – 200 mcsec Amplitude – 2.25 mA (1.6-3.0) Bologna 2010

  9. Results Angiographic vasospasm 9 events in 6 patients (50%) Clinical vasospasm 2 patients (17%) Bologna 2010

  10. Results Predicted rate of vasospasm – 50-80% angiographic, 33-40% clinical (based on H&H and Fisher grades) Actual rate of vasospasm – 50% angiographic, 17% clinical Long-term outcome: 1 death (during acute treatment)no disability, no stroke, no vasospasm-related adverse events Bologna 2010

  11. Conclusions • Cervical SCS electrodes may be safely implanted in patients with aneurysmal SAH • It is feasible to perform 2 week continuous SCS in high-intensity ICU settings • The vasospasm rate is lower than predicted • No vasospasm-related mortality / morbidity in entire cohort(12 months follow up completed in all patients) Bologna 2010

  12. Second hypothesis Bologna 2010

  13. Findings • Correlation between the position of active contacts within SCS electrode and vasospasm occurrence. • Clinical vasospasm occurred only in those patients who were stimulated at mid-cervical level (C4-5) (n=2) and not in those where active contacts were above C4 (n=10). Bologna 2010

  14. Conclusions • Cervical SCS electrodes may be safely implanted in patients with aneurysmal SAH • It is feasible to perform 2 week continuous SCS in high-intensity ICU settings • The vasospasm rate is lower than predicted • No vasospasm-related mortality / morbidity in entire cohort(12 months follow up completed in all patients) • Location of active cSCS contacts may contribute to prophylactic cSCS effects in post-aSAH vasospasm patients. Bologna 2010

More Related